Robert Andrew Rieger
4Patents
2h-index
28Co-inventors
40Inventor score
Filing activity: Dec 4, 2015 → Aug 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10730880B2 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors | Human Necessities | 3 | Active |
| US10189845B2 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors | Human Necessities | 2 | Active |
| US12351581B2 | Compounds for FGFR inhibition | Chemistry; Metallurgy | 0 | Active |
| US11028093B2 | 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.